Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

3D bioprinting technologies and biomaterial-based scaffolds for wound healing: Insights into decellularized tissue-derived bioinks

Khatibi A., Khazaei M., Zamani S., Al Jaf M., Rezakhani L.

Narrative Review on Chronic Wound, published in Regen Ther (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Regen Ther (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42255493
PMCID
PMC13242017
DOI
10.1016/j.reth.2026.101147

Abstract (original English)

The field of tissue engineering has witnessed significant advancements with the advent of 3D printing technologies, especially in wound healing. Innovative 3D-printed scaffolds incorporating decellularized biomaterials offer a promising approach to enhance the regenerative process. Decellularized biomaterials, derived from natural tissues, retain the extracellular matrix (ECM) components crucial for cell adhesion, migration, and tissue regeneration. These biomaterials are processed to remove cellular material, minimizing immune rejection and ensuring biocompatibility. When combined with the precision of 3D printing, these scaffolds can be tailored to match the specific needs of different wound types, promoting effective tissue integration and accelerated healing. This approach provides a platform for the creation of personalized, patient-specific treatments, addressing the limitations of traditional wound care strategies. Furthermore, the ability to print scaffolds with complex structures allows for the optimization of mechanical properties and porosity, facilitating nutrient exchange and cellular infiltration. This paper explores the potential of 3D-printed decellularized biomaterial scaffolds in revolutionizing wound healing, emphasizing their role in improving regenerative outcomes and reducing the risks of complications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research